Volume 65, Issue 4, Pages (April 2004)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Volume 127, Issue 6, Pages (June 2005)

Volume 54, Issue 3, Pages (September 1998)

Volume 11, Issue 6, Pages (June 2012)

Introduction The American Journal of Medicine

Reevaluation by High-Performance Liquid Chromatography: Clinical Significance of Microalbuminuria in Individuals at High Risk of Cardiovascular Disease.

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study Vasilios Papademetriou, MD, DSc, Eric.

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 66, Issue 3, Pages (September 2004)

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

Comorbidity and confounding in end-stage renal disease

Volume 66, Issue 3, Pages (September 2004)

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 7, Issue 11, (November 2010)

Volume 70, Issue 11, Pages (December 2006)

Volume 70, Issue 7, Pages (October 2006)

Renal risk scores: Progress and prospects

Volume 371, Issue 9627, Pages (May 2008)

Volume 75, Issue 8, Pages (April 2009)

Enlightenment on liver lanthanum exposure

Acute myocardial infarction in patients with end-stage renal disease

Volume 70, Issue 12, Pages (December 2006)

Anemia as a risk factor for cardiovascular disease

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Volume 61, Issue 4, Pages (April 2002)

Fructose intake as a risk factor for kidney stone disease

Volume 62, Issue 1, Pages (July 2002)

Should kidney donors be genotyped for APOL1 risk alleles?

Volume 89, Issue 5, Pages (May 2016)

The third World Kidney Day: Looking back and thinking forward

Alfonso M. Cueto-Manzano, Héctor R

Volume 66, Issue 2, Pages (August 2004)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

The kidney, a cardiovascular risk marker, and a new target for therapy

Volume 80, Issue 6, Pages (September 2011)

Volume 76, Issue 8, Pages (October 2009)

Volume 66, Issue 3, Pages (September 2004)

Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark

Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst

Volume 72, Issue 4, Pages (August 2007)

Volume 74, Issue 11, Pages (December 2008)

Long-term survival in renal transplant recipients with graft function

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Baseline Characteristics of the Patients - Part I

Volume 60, Issue 1, Pages (July 2001)

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Does equal care give equal outcomes?

Volume 62, Issue 4, Pages (October 2002)

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Volume 70, Issue 7, Pages (October 2006)

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Volume 67, Issue 5, Pages (May 2005)

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Volume 62, Issue 5, (November 2002)

Volume 64, Issue 4, Pages (October 2003)

Volume 82, Issue 9, Pages (November 2012)

Volume 76, Issue 5, Pages (September 2009)

Familial phenotype differences in PKD11

Volume 57, Pages S44-S48 (April 2000)

Ronen Levi, Justin Silver Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 65, Issue 4, Pages 1375-1380 (April 2004) Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study Johannes F.E. Mann, E.V.A.M. Lonn, Qilong Yi, Hertzel C. Gerstein, Byron J. Hoogwerf, Janice Pogue, Jackie Bosch, Gilles R. Dagenais, Salim Yusuf, on behalf of the HOPE Investigators Kidney International Volume 65, Issue 4, Pages 1375-1380 (April 2004) DOI: 10.1111/j.1523-1755.2004.00513.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier survival curves for the primary cardiovascular study outcome (myocardial infarction, stroke, cardiovascular death). The x-axis indicates the duration of follow-up in days. Kidney International 2004 65, 1375-1380DOI: (10.1111/j.1523-1755.2004.00513.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Median urinary albumin/creatinine ratio including 25 and 75 percentiles at baseline (left) and at study end (right) in the placebo and vitamin E treated groups, respectively. Kidney International 2004 65, 1375-1380DOI: (10.1111/j.1523-1755.2004.00513.x) Copyright © 2004 International Society of Nephrology Terms and Conditions